Baird Medical (BDMD) announced a strategic partnership with Stonewood Key Capital, a wholly-owned comprehensive investment management enterprise from New Zealand. This collaboration positions the Hainan Free Trade Port as a pivotal hub for the company’s cross-border operations and supply chain. By capitalizing on the Free Trade Port’s policies regarding cross-border capital flows and personnel mobility, the company aims to secure a competitive operational framework designed to meet rising demand for minimally invasive therapies addressing thyroid and other soft tissue applications.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDMD:
